NCT06809322
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06809322
Title Vorasidenib Maintenance for IDH Mutant Astrocytoma (VIGOR)
Acronym VIGOR
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | GBR | FRA | ESP | DEU | CZE | CHE | BEL | AUT